Pharmacy retail chain MedPlus Health Services Ltd on Tuesday (October 27) reported a 0.9% year-on-year increase in net profit to ₹56 crore for the second quarter of FY27, compared with ₹55.5 crore in the year-ago period.
Revenue rose 21.3% year-on-year to ₹2,037 crore from ₹1,679 crore. Revenue was up 8.4% sequentially, increasing ₹157.5 crore from the first quarter.
Earnings before interest, taxes, depreciation and amortisation (EBITDA) increased 14.1% to ₹170 crore from ₹149 crore, while the EBITDA margin declined to 8.4% from 8.9% a year earlier.
ALSO READ | MedPlus Health shares fall up to 18%, slip below IPO price, dragged by these factors
Gross margin stood at ₹510.8 crore, with the gross margin percentage at 25.1%, down 110 basis points year-on-year but up 60 basis points sequentially. Pharmacy operating earnings before interest, taxes, depreciation and amortisation (EBITDA) stood at ₹88.5 crore, with an operating EBITDA margin of 4.4%, up 120 basis points quarter-on-quarter. The company’s operating EBITDA was ₹98.1 crore.
MedPlus added 166 stores on a net basis during the quarter, including 219 gross additions and 101 net additions beyond Tier-I cities. Its total store count stood at 5,642 as of September 30, 2026. Stores operational for more than 12 months recorded 13.2% year-on-year revenue growth, a store-level EBITDA margin of 11.7% and store-level operating return on capital employed (ROCE) of 72%.
Operating cash flow for the quarter stood at ₹37 crore, equivalent to 37.7% of operating EBITDA. Closing cash, bank balances and investments totalled ₹543.9 crore, including ₹81.8 crore in investments.
ALSO READ | MedPlus Health Q1 net profit falls 22% as margins decline despite 22% revenue growth
For the first half of FY27, revenue grew 21.6% year-on-year to ₹3,916.7 crore, an increase of ₹694.7 crore over the corresponding period last year. Gross margin stood at ₹971.2 crore, with the gross margin percentage at 24.8%, down 130 basis points year-on-year.
MedPlus recorded 312 net store additions in H1 FY27, including 441 gross additions and 226 net additions beyond Tier-I cities. Stores operational for more than 12 months reported revenue growth of 14.9% year-on-year and a store-level EBITDA margin of 11.1%.
Pharmacy operating EBITDA for the first half stood at ₹147.3 crore, with a margin of 3.8%, down 100 basis points year-on-year. Company operating EBITDA was ₹163.2 crore. Operating cash flow reached ₹162.2 crore, equivalent to 99.4% of operating EBITDA, while closing cash, bank balances and investments stood at ₹543.9 crore, including ₹81.8 crore in investments.
ALSO READ | MedPlus puts ₹100 crore concierge healthcare project on hold after investor feedback
Shares of MedPlus Health Services Ltd ended at ₹624.00, up by ₹15.30, or 2.51%, on the BSE.